This session will provide an overview of reference safety information (e.g., Investigator Brochure), expectedness determination, and causality assessment of serious adverse events observed in interventional clinical trials.

参加申し込み

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 7: Assessing Individual Cases and Expedited Case Reporting, Part 1

Session Chair(s)

JP Clement, MD

最新情報や機会を逃さないで